Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CD33 antibody-guided imaging and treatment of acute myeloid leukemia

Anti-CD33 antibody-guided imaging and treatment of acute myeloid leukemia

US Patent 11666672 · Granted Jun 6, 2023

Estimated economic value: $4,208,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

TAG72 targeted chimeric antigen receptor modified T cells for treatment of TAG722025
NIR-conjugated tumor-specific antibodies and uses thereof2024
Multi-modal image-guided radiation system2023
NIR-conjugated tumor-specific antibodies and uses thereof2020
Single chain antibody domains for detection of anti-botulinum neurotoxin domains2019
Humanized anti-CEA T84.66 antibody and uses thereof2010
Humanized anti-CEA T84.66 antibody and uses thereof2007